5′ UTR miRNA TargetingJuly 21, 2014The nightly news lately makes it seem like the world has gone upside down, and now we’ve got some science to back it. Honglei Zhou and Isidore Rigoutsos from Thomas Jefferson University recently revealed that mammalian miRNA targeting doesn’t always limit itself to 3′ miRNA action. It now seems that in addition to the traditional 3’UTR […]
Grab an Epigenetics Position at Active MotifJuly 21, 2014Our colleagues at Active Motif are searching for a new member for their team in the position of Product Specialist – Europe. If you dig epigenetics, and think you’ve got some business and marketing skills to go with it, then this may be a great fit for you! The crew at Active Motif is great […]
Chromatin Packaging in Embryonic Stem Cells and SpermJuly 16, 2014Fitting all that chromatin into a tiny package is no easy ordeal, especially when pristine nuclear architecture is so crucial to things like cancer prevention. In order to learn more about the chromatin packaging of mouse embryonic stem cells (ESCs) and sperm, a team from the University of Massachusetts Medical School laid out some high-resolution nucleosome and transcription factor […]
Fetal Undernourishment Creates Temporary Transgenerational EffectJuly 11, 2014Transgenerational epigenetic inheritance is one hot topic, and it has long been shrouded in skepticism, but a number of cases and mechanistic insights into transgenerational epigenetic inheritance have helped molecular biology move past the limits of genetic determinism. Now a team from the University of Cambridge show that fetal nourishment results in a transgenerational epigenetic effect, rather than true […]
Reaction Biology Scores NIH Grant for Epigenetic Drug DatabaseJuly 11, 2014Epigenetic databases are one of of our favorite futuristic tools and now a time traveling crew from Reaction Biology Corporation (RBC) land a grant from the National Center for Advancing Translational Sciences (NCATS) to create an impressive database of epigenetic drug interactions. The team at RBC is undertaking a colossal effort examining a library of 1,400 compounds, including almost every FDA approved drug. […]
